FDA approves Lilly’s Taltz for treatment of ankylosing spondylitis

This article was originally published here

The latest FDA approval is the third for Taltz with the first one coming in 2016 for the treatment of adults with moderate to severe plaque psoriasis. The

The post FDA approves Lilly’s Taltz for treatment of ankylosing spondylitis appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply